RecruitingNCT06775665

A Real-World Study on Hypertrophic Cardiomyopathy in Chinese Population

Clinical Characteristics and Real-World Outcomes of Chinese Patients With Hypertrophic Cardiomyopathy: A Prospective Cohort Study

Sponsor

Second Affiliated Hospital, Zhejiang University, School of Medicine

Enrollment

3,000 participants

Start Date

Jun 1, 2026

Study Type

OBSERVATIONAL

Conditions

Hypertrophic Cardiomyopathy (HCM)

Summary

This study is a prospective cohort study aimed at exploring the baseline characteristics and treatment patterns of the Chinese population with hypertrophic cardiomyopathy (HCM) in real-world settings. The objective is to assess the real-world treatment approaches and longitudinal outcomes in this population.

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying No interventions were applied to the patients. for people with hypertrophic cardiomyopathy (hcm). The study is currently recruiting participants at 2 locations. People eligible for this study include aged 18 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.